Monday, June 24, 2019 Rare Immunodeficiency Yields Insights into Inflammatory Responses NIAID scientists and their international colleagues have identified a new primary immune deficiency disease called IL-6R deficiency in two people with eczema, recurrent skin and lung infections, and reduced inflammatory responses. Their work, published online today in the Journal of Experimental Medicine, yields insights into the function of IL-6, a cell-signaling molecule involved in inflammatory conditions such as rheumatoid arthritis. It also highlights potential side effects for treatments that block IL-6 signaling.     National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107